Fig. 10From: Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinomaHM13 Hypomethylation in HCC. A Expression levels in different CNV of HM13. B Correlation analysis between HM13 methylation and its expression. C The promoter methylation of HM13 in HCC. D Kaplan-Meier survival of the promoter methylation of HM13Back to article page